Skip to main content

Advertisement

SpringerLink
Log in

Staging of primary and secondary solid musculoskeletal tumors

  • Review Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Antonescu CR, Blay J-Y, Bovee J, Bridge JA, Cunha IW. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. WHO classification of tumours series. 2020;3(5):1–475.

  2. Trojani M, Coindre JM, Rouesse J, Bui NB, De Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984;33:37–42.

    Article  CAS  Google Scholar 

  3. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone. A Clinicopathologic Analysis with Emphasis on Histologic Grading. Cancer. 1977;40(2):818–31.

    Article  CAS  Google Scholar 

  4. Coindre J-M, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchère D, Sastre X, Vilain M-O, Bonichon F, Bui BN. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. Cancer. 2001;91(10):1914–26.

    Article  CAS  Google Scholar 

  5. Kneisl JS, Rosenberg AE, Anderson PM, Antonescu CR, Bruland OS, Cooper K, Horvai AE, Holt GE, O'Sullivan B, Patel SR, Rose P. Bone. AJCC Cancer Staging Manual 8th Edition. 2018;8:471–86.

  6. Yoon SS, Maki RG, Asare EA, Cooper K, Hornick JL, Lazar AJ, Keedy VL, Kirsch DG, Madewell JE, Panicek DM, Randall RL, Tedder PS, Pollock RE. Soft Tissue Sarcoma of the Trunk and Extremities. AJCC Cancer Staging Manual 8th Edition. 2018;8:507–15.

  7. Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours eigth edition. Union for International Cancer Control. 2017;8:1–400.

  8. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;153:106–20.

    Article  Google Scholar 

  9. Song TK, Harris J Jr, Raghavan S, Norton JA. Major Blood Vessel Reconstruction During Sarcoma Surgery. Arch Surg. 2009;144(9):817–22.

    Article  Google Scholar 

  10. Gustafson P, Åkerman M, Alvegård TA, Fletcher CDM, Rydholm A, Willén H, Coindre J-M. Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis—the SIN-system. Eur J Cancer. 2003;39(11):1568–76.

    Article  CAS  Google Scholar 

  11. Biermann JS, Hirbe A, Chow W, Bernthal NM, Boles S, Brigman B, Callan AK, Cranmer LD, Dianat S, Donnelly E, Frabbri N, et al. Bone Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). 2022;1. Available at https://www.nccn.org/guidelines/guidelines-detail.

  12. von Mehren M, Kane JM, Bui MM, Choy E, Connelly M, Dry S, Ganjoo KN, George S, Gonzales RJ, Heslin MJ et al. Soft Tissue Sarcoma. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). 2021;1. Available at https://www.nccn.org/guidelines/guidelines-detail.

  13. Holzapfel K, Regler J, Baum T, Rechl H, Specht K, Haller B, von Eisenhart-Rothe R, Gradinger R, Rummeny EJ, Woertler K. Local Staging of Soft-Tissue Sarcoma: Emphasis on Assessment of Neurovascular Encasement—Value of MR Imaging in 174 Confirmed Cases. Radiology. 2015;275(2):501–9.

    Article  Google Scholar 

  14. Panicek DM, Schwartz LH. Soft tissue edema around musculoskeletal sarcomas at magnetic resonance imaging. Sarcoma. 1997;1:189–91.

    Article  CAS  Google Scholar 

  15. Biondetti PR, Ehman RL. Soft-tissue sarcomas: use of textural patterns in skeletal muscle as a diagnostic feature in postoperative MR imaging. Radiology. 1992;183:845–8.

    Article  CAS  Google Scholar 

  16. Kroon HM, Bloem JL, Holscher HC, van der Woude H-J, Reignierse M, Taminiau AHM. MR imaging of edema accompanying benign and malignant bone tumors. Skeletal Radiol. 1994;23:261–9.

    Article  CAS  Google Scholar 

  17. Brisse H, Ollivier L, Edeline V, Pacquement H, Michon J, Glorion C, Neuenschwander S. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment. Pediatr Radiolo. 2004;34:595–602.

    Google Scholar 

  18. Rosenthal J, Cardona K, Sayyid SK, Perricone AJ, Reimer N, Monson D, Singer AD. Nodal metastases of soft tissue sarcomas: risk factors, imaging findings, and implications. Skeletal Radiol. 2020;49:221–9.

    Article  Google Scholar 

  19. Schwab JH, Boland PJ, Antonescu C, Bilsky MH, Healey JH. Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging. Cancer. 2007;110(8):1815–22.

    Article  Google Scholar 

  20. Tateishi U, Hasegawa T, Beppu Y, Kawai A, Satake M, Moriyama N. Prognostic significance of MRI findings in patients with myxoid-round cell liposarcoma. Am J Roentgenol. 2004;182(3):725–31.

    Article  Google Scholar 

  21. Portera CA Jr, Ho V, Patel SR, Hunt KK, Feig BW, Respondek PM, Yasko AW, Benjamin RS, Pollock RE, Pisters PW. Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001;91(3):585–91.

    Article  Google Scholar 

  22. Choi H, Varma DG, Fornage BD, Kim EE, Johnston DA. Soft-Tissue Sarcoma: MR Imaging vs Sonography for Detection of Local Recurrence After Surgery. Am J Roentgenol. 1991;157:353–8.

    Article  CAS  Google Scholar 

  23. Evilevitch V, Weber WA, Tap WD, Allen-Auerbach M, Chow K, Nelson SD, Eilber FR, Eckardt JJ, Elashoff RM, Phelps ME, Czernin J, Eilber FC. Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas. Clin Cancer Res. 2008;14(3):715–20.

    Article  CAS  Google Scholar 

  24. Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Elashoff D, Chow K, Evilevitch V, Eckardt JJ, Phelps ME, Weber WA, Eilber FC. FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clinc Cancer Res. 2009;15(8):2856–63.

    Article  CAS  Google Scholar 

  25. Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, Anderson B, Blair S, Burstein H, Crew H, Dang C et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Breast Cancer. NCCN Guidelines. 2022;1. Available at https://www.nccn.org/guidelines/guidelines-detail.

  26. Parker S, Tomlins A. Clinical Guidelines for the Management of Breast Cancer. Breast Cancer Expert Advisory Group. 2019. Available at https://www.england.nhs.uk/mids-east/wp-content/uploads/sites/7/2018/02/guidelines-for-the-management-of-breast-cancer-v1.pdf.

  27. Kalli S, Semine A, Cohen S, Naber SP, Makim SS, Bahl M. American Joint Committee on Cancer’s Staging System for Breast Cancer, Eighth Edition: What the Radiologist Needs to Know. Radiographics. 2018;38(7):1921–33.

    Article  Google Scholar 

  28. McCartan DP, Prichard RS, MacDermott RJ, Rothwell J, Geraghty J, Evoy D, Quinn CM, Skehan SJ, O’Doherty A, McDermott EW. “Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging.” British Journal of Surgery. 2016;103:839–44.

    Article  CAS  Google Scholar 

  29. Bruckmann NM, Kirchner J, Umutlu L, Fendler WP, Seifert R, Herrmann K, Bittner A-K, HOffmann O, MOhrmann S, Antke C, Schimmöller L, Ingenwerth M, Breuckmann K, Stang A, Buchbender C, Antoch G, Sawicki L. Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients. European Radiology. 2021;31:8714–24.

    Article  Google Scholar 

  30. Liu T, Cheng T, Xu W, Yan W-L, Liu J, Yang H-L. A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer. Skeletal Radiol. 2011;40(5):523–31.

    Article  Google Scholar 

  31. Rong J, Wang S, Ding Q, Yun M, Zheng Z, Ye S. Comparison of 18 FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis. Sur Oncol. 2013;22(2):86–91.

    Article  Google Scholar 

  32. Woolf DK, Padhani AR, Makris A. Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care? Ann Oncol. 2015;26:1048–57.

    Article  CAS  Google Scholar 

  33. Hamaoka T, Costelloe CM, Madewell JE, Liu P, Berry DA, Islam R, Theriault RL, Hortobagyi GN, Ueno NT. Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer. Br J Cancer. 2010;102:651–7.

    Article  CAS  Google Scholar 

  34. Kosmin M, Padhani AR, Gogbashian A, Woolf D, Ah-See M-L, Ostler P, Sutherland S, Miles D, Noble J, Koh D-M, Marshall A, Dunn J, Makris A. Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone. Radiology. 2020;00:1–8.

    Google Scholar 

  35. Schaeffer EM, Srinivas S, Antonarakis ES, Armstrong AJ, Cheng HH, D`Amico AV, Davis BJ, Desai N, Dorff T, Eastham JA. Prostate Cancer. NCCN Clinical Practice Guidelines in Oncology (“NCCN Guidelines”). 2022;1. Available at https://www.nccn.org/guidelines/guidelines-detail.

  36. Lengana T, Lawal IO, Boshomane TG, et al. 68Ga-PSMA PET/CT replacing bone scan in the initial staging of skeletal metastasis in prostate cancer: a fait accompli. Clin Genitourin Cancer. 2018;16:392–401.

    Article  Google Scholar 

  37. Kabunda J, Lerato G, Kalinda C, Aldous C, Pillay V, Nozipho N. Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal System. Clincal Nuclear Medicine. 2021;46(7):562–8.

    Article  Google Scholar 

  38. Roach PJ, Francis R, Emmett L, et al. The impact of 68Ga-PSMA PET/ CT on management intent in prostate cancer: results of an Australian prospective multicenter study. J Nucl Med. 2018;59:82–8.

    Article  CAS  Google Scholar 

  39. Otis-Chapados S, Goulet CR, Dubois G, Lavallée É, Dujardin T, Fradet Y, Lacombe L, Lodde M, Tiguert R, Toren P, Fradet V, Beauregard J-M, Buteau F-A, Pouliot F. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is accurate for high-grade prostate cancer bone staging when compared to bone scintigraphy. Can Urol Assoc J. 2021;15(10):301–7.

    Article  Google Scholar 

  40. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25:2359–81.

    Article  CAS  Google Scholar 

  41. Board I. Adult Positions. International Society for Clinical Densitometry Positions. 2019. Available at www.ISCD.org.

  42. Ettinger DS, Wood DE, Aisner DL, Akereley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D'Amico TA, DeCamp M, Dilling TJ, Dowell J, Gettinger S. Non-Small Cell Lung Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). 2022;1. Available at https://www.nccn.org/guidelines/guidelines-detail.

  43. Rami-Porta R, Call S, Dooms C, Obiols C, Sánchez M, Travis WD, Vollmer I. Lung cancer staging: a concise update. Eur Respir J. 2018;51(5):1800190. https://doi.org/10.1183/13993003.00190-2018.

  44. Katagiri H, Takahashi M, Inagaki J, Sugiura H, Ito S, Iwata H. Determining the Site of the Primary Cancer in Patients with Skeletal Metastasis of Unknown Origin. Cancer. 1999;86(3):533–7.

    Article  CAS  Google Scholar 

  45. Takagi T, Katagiri H, Kim Y, Suehara Y, Kubota D, Akaike K, Ishii M, Mukaihara K, Okubo T, Murata H, Takahashi M, Kaneko K, Saito T. Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases. Plos One. 2015;10(6):e0129428.

  46. Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet. 2012;379:1428–35.

    Article  Google Scholar 

  47. Varadhachary GR, Raber MN. Cancer of Unknown Primary Site. N Engl J Med. 2014;371:757–65.

    Article  CAS  Google Scholar 

  48. Lee MS, Sanoff HK. Cancer of unknown primary. BMJ. 2020;371:1–12.

    Google Scholar 

  49. Hemminki K, Riihimäki M, Sundquist K, Hemminki A. Site-specific survival rates for cancer of unknown primary according to location of metastases. Int J Cancer. 2013;133(1):182–9.

    Article  CAS  Google Scholar 

  50. Piccioli A, Maccauro G, Spinelli MS, Biagini R, Rossi B. Bone metastases of unknown origin: epidemiology and principles of management. J Orthopaed Traumatol. 2015;16:81–6.

    Article  Google Scholar 

  51. Pavlidis N, Briasoulisa E, Hainsworthb J, Grecob FA. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003;39:1990–2005.

    Article  CAS  Google Scholar 

  52. Ettinger DS, Stevenson MM, Ahn D, Bajor D, Muhammad B, Bowles DW, Brondfield S, Bykowski J, Ciunci C, Deneve J, Eaton KD et al. Occult Primary. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). 2022;1. Available at https://www.nccn.org/guidelines/guidelines-detail.

  53. Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Analysis of a diagnostic strategy for patients with suspected. J Clin Oncol. 1995;13:2094–103.

    Article  CAS  Google Scholar 

  54. Delgado-Bolton RC, Fernandez-Perez C, Gonzales-Mate A, Carreras JL. Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors. J Nucl Med. 2003;44:1301–14.

    Google Scholar 

  55. Lawrenz JM, Gordon J, George JM, Haben C, Rubin B, Ilaslan H, Mesko N, Nystrom L. Does PET/CT Aid in Detecting Primary Carcinoma in Patients with Skeletal Metastases of Unknown Primary? Clin Orthop Relat Res. 2019;478(11):2451–7.

    Article  Google Scholar 

  56. Orel SG, Weinstein SP, Schnall MD, Reynolds CA, Schuchter LM, Fraker DL, Solin LJ. Breast MR Imaging in Patients with Axillary Node Metastases and Unknown Primary Malignancy. Radiology. 1999;212:543–9.

    Article  CAS  Google Scholar 

  57. Miquelestorena-Standley E, Jourdan M-L, Collin C, Bouvier C, Larousserie F, Aubert S, Gomez-Brouchet A, Guinebretière J-M, Tallegas M, Brulin B, Le Nail L-R, Tallet A, Le Loarer F, Massiere J, Galant C, de Pinieux G. Effect of decalcification protocols on immunohistochemistry and molecular analyses of bone samples. Mod Pathol. 2020;33:1505–17.

    Article  CAS  Google Scholar 

  58. Patel IJ, Rahim S, Davidson J, Wilkins LR, Sarode R, Weinberg I. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations. J Vasc Interv Radiol. 2019;30(8):1168–84.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiology Department, Instituto de Ortopedia E Traumatologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

    Diogo Guilherme Leão Edelmuth, Paulo Victor Partezani Helito & Marcelo Bordalo

  2. Radiology Department, Instituto de Radiologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

    Diogo Guilherme Leão Edelmuth, Paulo Victor Partezani Helito & Marcelo Bordalo

  3. Pathology Department, Instituto de Ortopedia E Traumatologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

    Renée Zon Filippi

  4. Orthopedic Oncology Department, Instituto de Ortopedia E Traumatologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil

    André Mathias Baptista

Authors
  1. Diogo Guilherme Leão Edelmuth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paulo Victor Partezani Helito
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renée Zon Filippi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. André Mathias Baptista
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marcelo Bordalo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcelo Bordalo.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Edelmuth, D.G.L., Helito, P.V.P., Filippi, R.Z. et al. Staging of primary and secondary solid musculoskeletal tumors. Skeletal Radiol 52, 365–378 (2023). https://doi.org/10.1007/s00256-022-04118-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-022-04118-1

Keywords

Search

Navigation